BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24399184)

  • 1. Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis.
    Todoerti M; Maglione W; Bernero E; Bortoluzzi A; Colaci M; Galuppi E; Paolino S; Talarico R; Cutolo M; Ferri C; Trotta F; Bombardieri S; Montecucco CM; Sinigaglia L
    Reumatismo; 2013 Dec; 65(5):207-18. PubMed ID: 24399184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 update.
    Duarte AC; Santos-Faria D; Gonçalves MJ; Sepriano A; Mourão AF; Duarte C; Neves JS; Águeda AF; Ribeiro PA; Daniel A; Neto A; Cordeiro A; Rodrigues A; Barcelos A; Silva C; Ponte C; Vieira-Sousa E; Teixeira F; Oliveira-Ramos F; Araújo F; Barcelos F; Canhão H; Santos H; Ramos J; Polido-Pereira J; Tavares-Costa J; Melo Gomes JA; Cunha-Miranda L; Costa L; Cerqueira M; Cruz M; Santos MJ; Bernardes M; Oliveira P; Abreu P; Figueira R; Barros R; Falcão S; Pinto P; Pimenta S; Capela S; Teixeira V; Fonseca JE
    Acta Reumatol Port; 2017; 42(2):127-140. PubMed ID: 28535545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the "3E initiative"].
    De Leonardis F; Alivernini S; Bonacci E; Buono AM; Bombardieri S; Ferraccioli GF; Montecucco C; Sinigaglia L; Trotta F; Valentini G
    Reumatismo; 2010; 62(1):34-45. PubMed ID: 20390116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Portuguese recommendations for the use of methotrexate in the treatment of rheumatoid arthritis].
    Canhão H; Santos MJ; Costa L; Bogas M; Mourão AF; Machado P; Fonseca JE; Silva JA;
    Acta Reumatol Port; 2009; 34(1):78-95. PubMed ID: 19377402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian recommendations for use of methotrexate in patients with rheumatoid arthritis.
    Katchamart W; Bourré-Tessier J; Donka T; Drouin J; Rohekar G; Bykerk VP; Haraoui B; Leclerq S; Mosher DP; Pope JE; Shojania K; Thomson J; Thorne JC; Bombardier C;
    J Rheumatol; 2010 Jul; 37(7):1422-30. PubMed ID: 20516029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate treatment in rheumatoid arthritis: management in clinical remission, common infection and tuberculosis. Results from a systematic literature review.
    Bogas M; Machado P; Mourão AF; Costa L; Santos MJ; Fonseca JE; Silva JA; Canhão H
    Clin Rheumatol; 2010 Jun; 29(6):629-35. PubMed ID: 20140758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of recommendations on the use of methotrexate in rheumatoid arthritis.
    Valerio V; Kwok M; Loewen H; Winkler J; Mody GM; Scuccimarri R; Meltzer M; Mengistu Y; Feldman CH; Weinblatt ME; Lacaille D; Hitchon CA; Colmegna I
    Clin Rheumatol; 2021 Apr; 40(4):1259-1271. PubMed ID: 32876784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms.
    Cipriani P; Ruscitti P; Carubbi F; Liakouli V; Giacomelli R
    Clin Ther; 2014 Mar; 36(3):427-35. PubMed ID: 24612941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for the use of parenteral methotrexate in rheumatic diseases.
    Tornero Molina J; Calvo Alen J; Ballina J; Belmonte MÁ; Blanco FJ; Caracuel MÁ; Carbonell J; Corominas H; Chamizo E; Hidalgo C; Ivorra JR; Marenco JL; Moreno Muelas JV; Muñoz-Fernández S; Nolla JM; Pérez T; Sanmarti R; Trenor P; Urrego C; Vidal J; Rosas Gomez de Salazar J
    Reumatol Clin (Engl Ed); 2018; 14(3):142-149. PubMed ID: 28082032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chinese expert-based consensus for methotrexate in rheumatic diseases].
    Chinese Association of Rheumatology and Immunology Physicians
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):719-722. PubMed ID: 30293331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations by the Spanish Society of Rheumatology for the management of patients diagnosed with rheumatoid arthritis who cannot be treated with methotrexate.
    García-Vicuña R; Martín-Martínez MA; Gonzalez-Crespo MR; Tornero-Molina J; Fernández-Nebro A; Blanco-García FJ; Blanco-Alonso R; Marsal-Barril S;
    Reumatol Clin; 2017; 13(3):127-138. PubMed ID: 27825791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on methotrexate.
    Braun J; Rau R
    Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review.
    Wang W; Zhou H; Liu L
    Eur J Med Chem; 2018 Oct; 158():502-516. PubMed ID: 30243154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How to effectively use methotrexate in rheumatoid arthritis?].
    Hernandez-Baldizon S
    Reumatol Clin; 2012; 8(1):42-5. PubMed ID: 22089073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB; von Kempis J; Haile SR; Schiff MH
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to current recommendations on the use of methotrexate in rheumatoid arthritis in Italy: results from the MARI study.
    Manara M; Bianchi G; Bruschi E; Azzolini V; Belai Beyene N; Corbanese S; De Gennaro F; Martin-Martin LS; Molica Colella AB; Pozzi MR; Romeo N; Rossini T; Severino A; Sinigaglia L
    Clin Exp Rheumatol; 2016; 34(3):473-9. PubMed ID: 27050478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence and Persistence with Methotrexate in Rheumatoid Arthritis: A Systematic Review.
    Curtis JR; Bykerk VP; Aassi M; Schiff M
    J Rheumatol; 2016 Nov; 43(11):1997-2009. PubMed ID: 27803341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].
    Niehues T; Horneff G; Michels H; Sailer Höck M; Schuchmann L
    Z Rheumatol; 2004 Apr; 63(2):147-58. PubMed ID: 15112095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
    McLean-Tooke A; Aldridge C; Waugh S; Spickett GP; Kay L
    Rheumatology (Oxford); 2009 Aug; 48(8):867-71. PubMed ID: 19447771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.
    Visser K; Katchamart W; Loza E; Martinez-Lopez JA; Salliot C; Trudeau J; Bombardier C; Carmona L; van der Heijde D; Bijlsma JW; Boumpas DT; Canhao H; Edwards CJ; Hamuryudan V; Kvien TK; Leeb BF; Martín-Mola EM; Mielants H; Müller-Ladner U; Murphy G; Østergaard M; Pereira IA; Ramos-Remus C; Valentini G; Zochling J; Dougados M
    Ann Rheum Dis; 2009 Jul; 68(7):1086-93. PubMed ID: 19033291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.